TrialThe British journal of surgery2024

Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study.

Stefano Partelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.